tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AZN Stock Latest News

AstraZeneca’s MAA for sipavibart accepted by EMA for COVID-19 prevention
The FlyAstraZeneca’s MAA for sipavibart accepted by EMA for COVID-19 prevention
1d ago
AZN
AstraZeneca’s Imfinzi, Lynparza recommended for approval in EU by CHMP
PremiumThe Fly
AstraZeneca’s Imfinzi, Lynparza recommended for approval in EU by CHMP
1d ago
AZN
AstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
PremiumThe Fly
AstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
6d ago
AZN
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
PremiumGlobal Markets
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
7d ago
AZN
AstraZeneca’s Imfinzi demonstrated statistically significant improvement
PremiumThe Fly
AstraZeneca’s Imfinzi demonstrated statistically significant improvement
7d ago
AZN
AstraZeneca’s Tagrisso approved in Japan for 1st-line treatment
PremiumThe FlyAstraZeneca’s Tagrisso approved in Japan for 1st-line treatment
7d ago
AZN
AstraZeneca says ADJUVANT BR.31 Phase III trial did not achieve primary endpoint
PremiumThe Fly
AstraZeneca says ADJUVANT BR.31 Phase III trial did not achieve primary endpoint
7d ago
AZN
AstraZeneca reports Truqap plus Faslodex approved in EU for breast cancer
PremiumThe Fly
AstraZeneca reports Truqap plus Faslodex approved in EU for breast cancer
12d ago
AZN
AstraZeneca reports CAPItello-290 Phase 3 trial did not meet primary endpoints
PremiumThe Fly
AstraZeneca reports CAPItello-290 Phase 3 trial did not meet primary endpoints
14d ago
AZN
AstraZeneca: IMFINZI +chemo gets approval for endometrial cancer with dMMR
PremiumThe Fly
AstraZeneca: IMFINZI +chemo gets approval for endometrial cancer with dMMR
15d ago
AZN
AstraZeneca reports Imfinzi plus chemo approved for endometrial cancer in U.S.
PremiumThe Fly
AstraZeneca reports Imfinzi plus chemo approved for endometrial cancer in U.S.
15d ago
AZN
AstraZeneca announces results from ECHO Phase III trial
PremiumThe Fly
AstraZeneca announces results from ECHO Phase III trial
16d ago
AZN
AstraZeneca’s Farxiga approved by FDA to treat pediatric diabetes
PremiumThe FlyAstraZeneca’s Farxiga approved by FDA to treat pediatric diabetes
20d ago
AZN
AstraZeneca price target raised to 15,000 GBp from 13,000 GBp at Berenberg
PremiumThe Fly
AstraZeneca price target raised to 15,000 GBp from 13,000 GBp at Berenberg
22d ago
AZN
FDA grants priority review to AstraZeneca’s Tagrisso for EGFRm NSLC
PremiumThe Fly
FDA grants priority review to AstraZeneca’s Tagrisso for EGFRm NSLC
22d ago
AZN
AstraZeneca’s sNDA for Tagrisso granted Priority Review in U.S.
PremiumThe Fly
AstraZeneca’s sNDA for Tagrisso granted Priority Review in U.S.
22d ago
AZN
AstraZeneca Completes Fusion Pharmaceuticals Acquisition
PremiumCompany Announcements
AstraZeneca Completes Fusion Pharmaceuticals Acquisition
28d ago
6K
AZN
AstraZeneca completes acquisition of Fusion Pharmaceuticals
PremiumThe Fly
AstraZeneca completes acquisition of Fusion Pharmaceuticals
28d ago
AZN
FUSN
Regeneron price target raised to $1,200 from $1,185 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $1,200 from $1,185 at RBC Capital
28d ago
AZN
AMGN
AstraZeneca reports Tagrisso plus chemo recommended for approval in EU
PremiumThe FlyAstraZeneca reports Tagrisso plus chemo recommended for approval in EU
29d ago
AZN
AstraZeneca presents results from LAURA Phase III trial
PremiumThe Fly
AstraZeneca presents results from LAURA Phase III trial
30d ago
AZN
AstraZeneca presents results from ADRIATIC Phase III trial
PremiumThe Fly
AstraZeneca presents results from ADRIATIC Phase III trial
30d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >